Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?
Lymphedema is a debilitating disorder that severely impairs the quality of life of the patients and requires life-long attention. Treatment for lymphatic dysfunction remains largely symptomatic, without real cure. According to the International Society of Lymphology, lymphedema has to be treated with Decongestive Lymphatic Therapy. Research in the lab of Angiogenesis and Vascular Metabolism (PCA lab) reported in mice that metabolism of endothelial cells controls vessel sprouting. Experiments showed that a ketogenic diet (KD) reduced the edema of the mice tail and enhanced the lymphatic transport. Based on these proof-of-concept data, the investigators plan to test this innovative concept to ameliorate lymph vessel dysfunction in lymphedema patients. Randomisation will be performed between a ketogenic diet and an isocaloric diet with and without ketone ester supplementation.
• \>18 years;
• unilateral lymphedema of the arm lymph node dissection
• lymphedema onset less than a year before the therapy starts
• lymphedema defined as \>3% volume difference between both arms
• lymphedema stage 1, stage 2a or stage 2b
• absence of pregnancy at the time of enrollment and willingness to use adequate contraceptive measures until the end of the study;
• oral and written approval of the informed consent presented at the time of the consultation by the physicians;
• understanding Dutch